AzTrials
AzTrials

Chronic Venous InsufficiencyPhase 4NCT01372020

Neuromuscular Electrical Therapy in Venous Ulcers

A Phase 4 study testing neuromuscular electrical stimulation in people with Chronic Venous Insufficiency, run by Faculdade Evangelica do Parana at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The use of neuromuscular electrical stimulation in the treatment of venous ulcers with difficulty of repair could be an alternative therapeutic favoring devitalized tissues and hence the pain. Read more about this study

Who is it for?
Ages 50 to 85 years
Conditions the study is for
Chronic Venous Insufficiency
What is being tested?
neuromuscular electrical stimulation
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteBrazil
Study dates
Feb 2011to Nov 2011
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects of both genders
  • aged over 50 years
  • sedentary and with clinical diagnosis of chronic venous insufficiency with ulcer in lower limbs will be included

Who cannot join

  • Subjects with pacemakers
  • diabetes
  • uncontrolled hypertension
  • osteomyelitis and pain of unknown origin
  • unable to walk or make use of drugs that acted directly on the healing process will be excluded

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Faculdade Dom Bosco

    Curitiba, Paraná, 55

Other trials in Brazil

About this study

Official title: The Effect of Neuromuscular Electrical Therapy on Pain in Patients With Venous Ulcers: a Controlled Clinical Trial

The use of neuromuscular electrical stimulation in the treatment of venous ulcers with difficulty of repair could be an alternative therapeutic favoring devitalized tissues and hence the pain.

The aim of this study is to evaluate the effect of neuromuscular electrical stimulation on pain and area of venous ulcers in patients with venous insufficiency.

Read the detailed description

The aim was to evaluate the effect of neuromuscular electrical stimulation on pain and area of venous ulcers in patients with venous insufficiency. In a simple-blind controlled clinical study, 20 subjects with venous ulcers with age over 50 years will be divided in two groups:neuromuscular electrical stimulation(n=10) and control group (n=10). Pain (by Visual Analogue Scale) and the ulcer area (by planimetry on graph paper and the software ImageJ ®) were measured.

Being tested
neuromuscular electrical stimulation
Keywords
Varicose ulcer, wound healing, electrical stimulation
Medical subject headings
Varicose Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neuromuscular electrical stimulationOther

    Also called intervention group

    The application technique used will be bipolar, with electrodes of the type metal-tipped pen. The electrodes will be placed at the outer edges of the ulcer, on opposite sides of the same and the estimated time of 1 minute at each point. All the edge of the ulcer will be bypassed, thereby separating the injections every 1 cm, returning to the starting point at the end of the application. To ensure that the entire edge of the ulcer to receive the stimulation, the end points of the application, the application will be made for another minute sliding the pen around the whole edge. Thus the application time will be directly proportional to the ulcer area. The subjects will be received 10 applications, three times a week for a period of 4 weeks.

Study groups in NCT01372020
Study groupRoleWhat they receive
control groupSham comparatorNot described
Receives: Other: neuromuscular electrical stimulation
neuromuscular electrical therapyExperimentalNot described
Receives: Other: neuromuscular electrical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain

    Pain assessment will be performed by the Visual Analogue Scale

    Measured: the subjects will be followed for a period of 4 weeks.

Secondary outcomes (1)
  1. ulcer area

    the ulcer area will be measured by the planimetry.

    Measured: the patients will be folloed for the 4-weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2011 (estimated)
  2. Study startFeb 2011
  3. Primary completionSep 2011
  4. Study completionNov 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01372020
Sponsor's protocol ID
fepar-04
Status last verified
Dec 2013
First submitted
9 Jun 2011
Last updated
24 Dec 2013
Results posted
No
Data monitoring committee
No

Publications

  • Carley PJ, Wainapel SF. Electrotherapy for acceleration of wound healing: low intensity direct current. Arch Phys Med Rehabil. 1985 Jul;66(7):443-6.

    PubMed 3893385
  • Korelo RI, Valderramas S, Ternoski B, Medeiros DS, Andres LF, Adolph SM. Microcurrent application as analgesic treatment in venous ulcers: a pilot study. Rev Lat Am Enfermagem. 2012 Jul-Aug;20(4):753-60. doi: 10.1590/s0104-11692012000400016. English, Portuguese, Spanish.

    PubMed 22990161

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing neuromuscular electrical stimulation in people with Chronic Venous Insufficiency, run by Faculdade Evangelica do Parana at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (time frame: the subjects will be followed for a period of 4 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01372020, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in